Toll-like receptor 4: A target for chemoprevention of hepatocellular carcinoma in obesity and steatohepatitis

Jennifer Nguyen, Jingjing Jiao, Kristin Smoot, Gordon P. Watt, Chen Zhao, Xingzhi Song, Heather L. Stevenson, Joseph B. McCormick, Susan P. Fisher-Hoch, Jianhua Zhang, P. Andrew Futreal, Laura Beretta

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

The incidence of hepatocellular carcinoma (HCC) associated with non-alcoholic fatty liver disease (NAFLD) is rapidly increasing. We aimed to elucidate the genetic basis of NAFLD-associated HCC and identify candidate targets for chemoprevention. Twenty HCC tumors, distant liver and matched tails from mice with hepatocytedeletion of Pten (HepPten-) were subjected to whole-exome sequencing. A total of 162 genes with somatic non-synonymous single nucleotide variants or exonic small insertions and deletions in tumors were identified. Ingenuity Pathway Analysis of these 162 genes, further identified Toll-like receptor (TLR) 4, a key mediator of proinflammatory responses, and resatorvid, a TLR4 inhibitor, as the main causal networks of this dataset. Resatorvid treatment strongly prevented HCC development in these mice (p < 0.001). Remarkably, HCC patients with high tumoral TLR4 mRNA expression were more likely to be diagnosed with NAFLD and obese. TLR4 mRNA expression positively correlated with IL-6 and IL-10 mRNA expression in HCC tumors and the correlation was stronger in obese HCC patients. We have identified tumor mutation signatures and associated causal networks in NAFLD-associated HCC in HepPten- mice and further demonstrated the important role of TLR4 in promoting HCC development. This study also identified IL-6 and IL-10 as markers of TLR4 activation in HCC and subjects with NAFLD and obesity as the target population who would benefit from TLR4 inhibition treatment for HCC chemoprevention.

Original languageEnglish (US)
Pages (from-to)29495-29507
Number of pages13
JournalOncotarget
Volume9
Issue number50
DOIs
StatePublished - Jun 29 2018

Keywords

  • Chemoprevention
  • Hepatocellular carcinoma
  • Mouse model
  • NAFLD
  • Toll-like receptor 4

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Toll-like receptor 4: A target for chemoprevention of hepatocellular carcinoma in obesity and steatohepatitis'. Together they form a unique fingerprint.

  • Cite this

    Nguyen, J., Jiao, J., Smoot, K., Watt, G. P., Zhao, C., Song, X., Stevenson, H. L., McCormick, J. B., Fisher-Hoch, S. P., Zhang, J., Andrew Futreal, P., & Beretta, L. (2018). Toll-like receptor 4: A target for chemoprevention of hepatocellular carcinoma in obesity and steatohepatitis. Oncotarget, 9(50), 29495-29507. https://doi.org/10.18632/oncotarget.25685